Table: Immuno Biological Lab -2017/18 group results

Immuno-Biological Laboratories

14/05/2018 07:30

May 14 (Reuters)- 
          Immuno Biological Laboratories Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended       Year ended       Year to        NEXT   
              Mar 31, 2018     Mar 31, 2017    Mar 31, 2019     YEAR     
                 LATEST          YEAR-AGO        COMPANY       COMPANY   
                 RESULTS         RESULTS         FORECAST    H1 FORECAST 
  Sales          758 mln         741 mln         982 mln                 
               (+2.3 pct)       (+3.3 pct)     (+29.6 pct)               
  Operating    loss 48 mln      loss 1.16      loss 25 mln               
  Recurring    loss 49 mln      loss 1.17      loss 24 mln               
  Net
  Net          loss 52 mln      loss 2.09      loss 39 mln               
  EPS         loss 7.01 yen  loss 287.52 yen  loss 4.68 yen              
  Ann Div          NIL             NIL             NIL                   
  -Q2 Div          NIL             NIL             NIL                   
  -Q4 Div          NIL             NIL             NIL                   
  
  NOTE - Immuno Biological Laboratories Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T